Contact us
Our partnering team
Our partnering team is integrated and designed to incorporate early input from experts in business development, R&D and commercial. Our team has extensive experience in identifying synergistic opportunities which are complementary to our capabilities and facilitating successful collaborations through effective alliance management.
Our dedicated business development teams are responsible for scouting for late-stage opportunities as well as facilitating the transactional aspects of the deal. Our R&D strategy teams are tasked with sourcing early stage innovation from both inside and outside the organisation, and are involved in the evaluation process of all deals from day one.
If you want to discuss how we can help you to leverage your regional commercial capabilities, please contact our regional and corporate business development team. Our Venture Capital Interaction Team (VCIT) is focused on proactively interacting with VCs.
Partnering leadership team
Areas of interest
Cardiovascular & Metabolic Diseases
| Small molecule business development | R&D Strategy Head | Biologics business development |
|---|---|---|
| Christoph Pittius
VP SPBD, CVGI |
James Hall
VP Strategy, CVGI |
Eric Victory
VP, Corporate Development |
Oncology
| Small molecule business development | R&D Strategy Head | Biologics business development |
|---|---|---|
|
VP SPBD, Oncology and STL |
VP Strategy, Oncology |
Director, Business Development |
Respiratory, Inflammation & Autoimmune
| Small molecule business development | R&D Strategy Head | Biologics business development |
|---|---|---|
|
VP SPBD, R&I and New Opportunities |
VP Strategy, R&I |
Associate Director, Business Development |
Infection
| Small molecule business development | R&D Strategy Head | Biologics business development |
|---|---|---|
|
VP SPBD, Infection and PHB |
VP Strategy, Infection |
Associate Director, Business Development |
Neuroscience
| Small molecule business development | R&D Strategy Head | Biologics business development |
|---|---|---|
|
VP New Business Development, Neuroscience |
VP Strategy, Neuroscience |
Senior Manager, Business Development |
New opportunities
| Small molecule business development | R&D Strategy Head | Biologics business development |
|---|---|---|
|
Executive Business Development Director |
VP Strategy, New Opportunities |
Vice-President, Corporate Business Development |
Personalised Healthcare & Biomarkers (PHB)
| Small molecule business development | R&D Strategy Head | Biologics business development |
|---|---|---|
|
Executive Business Development Director, Personalised Healthcare |
VP Strategy, PHB |
Senior Director, Business Development |
Science & Technology (STL)
| Small molecule business development | R&D Strategy Head | Biologics business development |
|---|---|---|
|
Executive Business Development Director, STL |
n/a |
Senior Director, Business Development |
Regional and corporate business development
Russell Gantt
VP Regional and Corporate Business Development
Denise E Goode
Executive Director, Regional & Corporate Business Development
Jeanette Evans
Executive Director, Regional & Corporate Business Development
Jeanette.Evans@astrazeneca.com
Mahmood Ladha
Executive Director, Regional & Corporate Business Development
Mahmood.Ladha2@astrazeneca.com
Europe, Middle East, Africa
Geoff Collett
Regional Business Development Director
USA
Will Mongon
Executive Director, US Business development
Asia Pacific
Augustine Yee
Regional Business Development Director
Japan
Russell Gantt
VP Regional and Corporate Business Development
General Enquiries
Chris Yochim
Director External Relations
Venture Capital enquiries
| Area | Key Contact |
|---|---|
| All enquiries |
Mark Rogers |